Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VIPR2 | P41587 | 6/20 | 0.43 |
| ▸ | VIPR1 | P32241 | 3/20 | 0.43 |
| ▸ | NPY4R | P50391 | 5/20 | 0.43 |
| ▸ | NPY1R | P25929 | 4/20 | 0.43 |
| ▸ | NPY2R | P49146 | 4/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.43 |
| ▸ | CTSD | P07339 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29422990 | 1.00 | VIPR2 (0.43) | VIPR2VIPR1NPY4RNPY1RNPY2R | |
| SCHEMBL30826388 | 0.96 | BACE1 (0.46) | NPY4RNPY1RNPY2RNPY5RCTSD | |
| SCHEMBL29500481 | 0.94 | VIPR2 (0.49) | VIPR2VIPR1CTSDBACE1 | |
| SCHEMBL29406555 | 0.94 | VIPR2 (0.49) | VIPR2VIPR1CTSDBACE1 | |
| SCHEMBL30378956 | 0.92 | VIPR2 (0.45) | VIPR2VIPR1NPY4RNPY1RNPY2R | |
| SCHEMBL10943030 | 0.92 | NPY4R (0.49) | NPY4RNPY1RNPY2RNPY5RCTSD | |
| SCHEMBL30680480 | 0.92 | NPY4R (0.49) | NPY4RNPY1RNPY2RNPY5RCTSD | |
| SCHEMBL31756878 | 0.90 | NPY4R (0.45) | VIPR2VIPR1NPY4RNPY1RNPY2R | |
| SCHEMBL31188463 | 0.90 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RCTSD | |
| SCHEMBL30512671 | 0.90 | ENPEP (0.50) | VIPR2VIPR1BACE1F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119119235-A | Acylated glucagon analogues | 西兰制药公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-119119233-A | Acylated glucagon analogues | 西兰制药公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-119119234-A | Acylated glucagon analogues | 西兰制药公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-105745222-B | Acylated glucagon analogues | 西兰制药公司 | 2024-09-13 | — | — | CN | disclosed |